CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-19 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −5,727 | 73,203 | ||
| 2021-01-19 | Astley-Sparke Philip Chief Executive Officer | Sale | −800 | $43.15 | $35K | 1,262,929 |
| 2021-01-19 | Astley-Sparke Philip Chief Executive Officer | Sale | −7,632 | $42.40 | $324K | 1,255,297 |
| 2021-01-19 | Esposito Pamela Chief Business Officer | Option exercise | +5,727 | $1.01 | $6K | 181,721 |
| 2021-01-19 | Esposito Pamela Chief Business Officer | Sale | −600 | $43.24 | $26K | 181,121 |
| 2021-01-19 | Esposito Pamela Chief Business Officer | Sale | −5,127 | $42.38 | $217K | 175,994 |
| 2021-01-19 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −5,727 | 73,203 | ||
| 2021-01-19 | Love Colin Chief Operating Officer | Sale | −700 | $43.25 | $30K | 953,681 |
| 2021-01-19 | Love Colin Chief Operating Officer | Sale | −7,157 | $42.38 | $303K | 946,524 |
| 2021-01-15 | Esposito Pamela Chief Business Officer | Option exercise | +29,273 | $1.01 | $30K | 205,267 |
| 2021-01-15 | Esposito Pamela Chief Business Officer | Sale | −29,273 | $43.58 | $1.3M | 175,994 |
| 2021-01-15 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −29,273 | 78,930 | ||
| 2021-01-15 | Astley-Sparke Philip Chief Executive Officer | Sale | −1,100 | $44.95 | $49K | 1,279,197 |
| 2021-01-15 | Astley-Sparke Philip Chief Executive Officer | Sale | −6,059 | $43.71 | $265K | 1,273,138 |
| 2021-01-15 | Astley-Sparke Philip Chief Executive Officer | Sale | −9,409 | $43.02 | $405K | 1,263,729 |
| 2021-01-15 | Esposito Pamela Chief Business Officer | Option exercise | +29,273 | $1.01 | $30K | 205,267 |
| 2021-01-15 | Esposito Pamela Chief Business Officer | Sale | −29,273 | $43.58 | $1.3M | 175,994 |
| 2021-01-15 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −29,273 | 78,930 | ||
| 2021-01-15 | Love Colin Chief Operating Officer | Sale | −2,200 | $45.01 | $99K | 974,324 |
| 2021-01-15 | Love Colin Chief Operating Officer | Sale | −7,547 | $43.80 | $331K | 966,777 |
Page 16 of 19 · 365 trades